Opaleye Management Inc. 13D and 13G filings for Context Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-05 4:05 pm Purchase | 2023-12-27 | 13G | Context Therapeutics Inc. CNTX | Opaleye Management Inc. | 820,000 5.140% | 820,000 (New Position) | Filing |